I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
Glucagon-Like Peptide-1 is used as a Effector in the hormonal control of insulin secretion. The peptide fragment is secreted from the lower small intestine. Its action is mediated by receptors expressed by the endocrine pancreatic B-cells.
Sadikot.; Ruxana T.; Rubinstein.; Israel. Long-Acting, Multi-Targeted Nanomedicine: Addressing Unmet Medical Need in Acute Lung Injury. Journal of Biomedical Nanotechnology. 2005, 5, (6), 614-619.
Abba J. Kastin.; Victoria Akerstrom.; Weihong Pan. Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. Journal of Molecular Neuroscience. 2002, 18, (1), 7-14.